Your browser doesn't support javascript.
loading
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
Sacco, Chiara; Del Manso, Martina; Mateo-Urdiales, Alberto; Rota, Maria Cristina; Petrone, Daniele; Riccardo, Flavia; Bella, Antonino; Siddu, Andrea; Battilomo, Serena; Proietti, Valeria; Popoli, Patrizia; Menniti Ippolito, Francesca; Palamara, Anna Teresa; Brusaferro, Silvio; Rezza, Giovanni; Pezzotti, Patrizio; Fabiani, Massimo.
Afiliación
  • Sacco C; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: chiara.sacco@iss.it.
  • Del Manso M; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Mateo-Urdiales A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Rota MC; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Petrone D; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Riccardo F; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Bella A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Siddu A; General Directorate of Prevention, Ministero della Salute, Rome, Italy.
  • Battilomo S; General Directorate of Health Information System and Statistics, Ministero della Salute, Rome, Italy.
  • Proietti V; General Directorate of Health Information System and Statistics, Ministero della Salute, Rome, Italy.
  • Popoli P; National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
  • Menniti Ippolito F; National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.
  • Palamara AT; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Brusaferro S; Office of the President, Istituto Superiore di Sanità, Rome, Italy.
  • Rezza G; General Directorate of Prevention, Ministero della Salute, Rome, Italy.
  • Pezzotti P; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Fabiani M; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Lancet ; 400(10346): 97-103, 2022 07 09.
Article en En | MEDLINE | ID: mdl-35780801
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido